Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MYDGF | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
mRNA | NPHP1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
mRNA | TGM5 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
mRNA | NANOS3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | MIB1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | JMJD6 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
mRNA | SPCS2 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |
mRNA | GLE1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
mRNA | SOCS3 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |
mRNA | FGFR2 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |